Feldt-Rasmussen U, Bech K, Date J, Thyme S, Hannover Larsen J, Nielsen H
Acta Pathol Microbiol Scand C. 1979 Dec;87(6):365-70.
The occurrence of anticomplementary activity and its correlation to serum thyroglobulin was investigated in 71 patients with thyroid diseases and 63 age and sex matched control subjects. The patients which were subgrouped according to thyroid function and characteristics of the goiter, were examined at the time of diagnosis. The anticomplementary activity was measured by a complement consumption (CC) assay. Sera from patients with Graves' disease and nontoxic diffuse goiter, showed stronger activity than sera from patients with nontoxic goiter. Seventeen of the patients and one of the controls were positive in the CC-assay. The percentage hemoglobin release in this assay was normally distributed using control sera but not for the patient group. There was no correlation either between CC-activity and serum concentrations of thyroglobulin or CC-activity and antibodies to the O-antigen of Yersinia enterocolitica serotype 3, thyroid cytoplasma, thyroglobulin, nuclear factors, streptolysin O, streptococ hyaluronidase, and parietal cells, respectively. However, correlation between the levels of thyroid stimulating immunoglobulins and CC-activity, was noted (Rho = 0.511, P less than 0.05), which suggests that these immunoglobulins also are present as immune complexes. Thyroglobulin--antithyroglobulin complexes preformed in vitro at high thyroglobulin concentration, gave negative results in the CC-assay.
对71例甲状腺疾病患者和63例年龄及性别相匹配的对照者,研究了抗补体活性及其与血清甲状腺球蛋白的相关性。根据甲状腺功能和甲状腺肿特征将患者分组,在诊断时进行检查。抗补体活性通过补体消耗(CC)试验测定。格雷夫斯病和非毒性弥漫性甲状腺肿患者的血清,比非毒性甲状腺肿患者的血清显示出更强的活性。17例患者和1例对照者的CC试验呈阳性。该试验中血红蛋白释放百分比在使用对照血清时呈正态分布,但患者组并非如此。CC活性与甲状腺球蛋白血清浓度之间、CC活性与抗小肠结肠炎耶尔森菌3型O抗原、甲状腺细胞质、甲状腺球蛋白、核因子、链球菌溶血素O、链球菌透明质酸酶和壁细胞抗体之间均无相关性。然而,观察到促甲状腺素受体抗体水平与CC活性之间存在相关性(Rho = 0.511,P<0.05),这表明这些免疫球蛋白也以免疫复合物形式存在。在高甲状腺球蛋白浓度下体外预先形成的甲状腺球蛋白 - 抗甲状腺球蛋白复合物,在CC试验中呈阴性结果。